BIOCYTOGEN
21.6.2024 12:51:24 CEST | Business Wire | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.
RenLite® mice, developed using Biocytogen’s proprietary Size-Unlimited and Precise Chromosome Engineering (SUPCETM) technology, feature the in situ replacement of the entire human antibody heavy chain variable region genes and a single light chain variable region gene. This enables the generation of highly diverse fully human antibodies that share a common light chain, effectively avoiding light-heavy chain mismatches during the assembly of bispecific antibodies, thereby significantly reducing the complexity of the CMC process. The molecular structures of these bispecific antibodies resemble monoclonal antibodies, exhibiting favorable physicochemical properties. Leveraging RenLite® and RenLite® KO mice, Biocytogen has generated a library of antibodies targeting over 200 TAA targets, enabling the rapid development of bispecific antibody and bispecific antibody-drug-conjugate (ADC) therapies.
In addition to the RenLite® platform, Biocytogen’s independently developed RenMice® series includes RenMabTM, RenNano®, RenTCRTM and RenTCR-mimicTM platforms. These five fully human antibody/TCR mouse platforms cater to the diverse R&D needs of pharmaceutical companies globally. Since their debut in 2019, the RenMice® platforms have garnered widespread recognition within the biotech and pharmaceutical industries. As of December 31, 2023, Biocytogen has established 47 target-nominated RenMice® licensing projects with over 20 multinational corporations (MNCs) and biopharmaceutical/biotech companies, including Merck KGaA, Janssen, Xencor, BeiGene and Innovent. The RenMice® platform has generated a library of over 400,000 fully human antibodies against thousands of targets and high-quality candidate antibodies, facilitating 103 projects encompassing co-development, out-licensing, and transfer agreements.
The U.S. patent authorization for the RenLite® platform technology demonstrates Biocytogen’s exceptional innovation capabilities and global competitiveness. Biocytogen will continue to pursue global patent strategies and protect key technologies, offering advanced technology platforms and robust intellectual property protection for its partners. Besides the United States, patent applications for the RenLite® platform have been submitted in China, Europe, Japan, South Korea, Canada, Singapore, Russia, Israel, Australia, and other countries and regions with authorizations in progress.
About Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMabTM/RenLite®/RenNano®/RenTCR-mimicTM) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologicsTM, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. As of December 31, 2023, 103 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and 47 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice®, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240620000304/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PUR Appoints Dr. Daniel Klier as Chief Executive Officer24.2.2026 09:00:00 CET | Press release
Seasoned sustainability and climate finance leader to guide PUR’s next phase of growth PUR (the “Company”), a pioneer in Nature-based Solutions, today announced the appointment of Dr. Daniel Klier as Chief Executive Officer, subject to regulatory approval. Founded nearly two decades ago, PUR partners with farming communities globally to deliver agroforestry, reforestation, and landscape restoration projects. The Company generates verified carbon reductions and carbon credits that help corporates reduce supply chain emissions through high-integrity insetting and climate contributions within and beyond their own value chains, while improving soil health, water resources, and long-term farm productivity. PUR is a recognized leader in resilient coffee and cocoa value chains, reforestation, mangrove restoration, and ecosystem conservation, delivering measurable benefits for ecosystems, agriculture, and farming communities. Dr. Klier’s appointment marks the next phase of PUR’s development as
BearingPoint launches new services to help organizations gain full software transparency and meet EU Cyber Resilience Act requirements ahead of the 2027 deadline24.2.2026 09:00:00 CET | Press release
BearingPoint’s new SBOM Management and CRA Compliance Services strengthen software supply chain security. BearingPoint announces the launch of two new service offerings designed to address the growing complexity of software supply chains and the upcoming regulatory requirements under the EU Cyber Resilience Act (CRA): SBOM Management Services and CRA Compliance Services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224192962/en/ BearingPoint announces the launch of two new service offerings designed to address the growing complexity of software supply chains and the upcoming regulatory requirements under the EU Cyber Resilience Act (CRA): SBOM Management Services and CRA Compliance Services. Modern software products often contain thousands of components, many of which are open source or sourced from third-party suppliers. As supply chain attacks become more frequent and regulations tighten, organizations need complete v
Thredd Powers MuchBetter's Expansion into Israel, Supporting Global Growth Strategy24.2.2026 09:00:00 CET | Press release
Launch reflects accelerating international momentum across the UK, Canada and beyond Thredd, the AI-first issuer processing platform, today announced the expansion of their partnership with MuchBetter, the consumer wallet and prepaid card platform, supporting the company’s launch in Israel. This marks the latest milestone in MuchBetter’s international expansion, powered by Thredd, following the successful deployment of their programme in the UK and Canada. Through the partnership, Thredd is providing processing infrastructure for MuchBetter’s prepaid card and digital wallet programme, enabling consumers in Israel to securely load funds and make payments using physical and virtual cards, with additional form factors planned as the programme scales. “International expansion is a core part of MuchBetter’s growth strategy, and Thredd has been a critical partner in helping us move quickly and confidently into new markets,” said Israel Rosenthal, Founder and CEO of MuchBetter. “Launching in
Cambridge Drives a New Era of Digital Maturity for the Age of AI24.2.2026 08:10:00 CET | Press release
Updated Cambridge Primary and Lower Secondary Digital Literacy curricula provide future-facing framework for responsible AI and media literacyBold curriculum update empowers children to think critically, act responsibly and shape, not just consume, technology As digital literacy moves to the forefront of education reforms worldwide, the International Education group at Cambridge University Press & Assessment (Cambridge) today announces a major transformation of its Cambridge Primary and Lower Secondary Digital Literacy curricula, redefining what it means for young people to thrive in an AI-powered world. Designed for learners aged 5–14, the updated Cambridge Primary Digital Literacy and Lower Secondary Digital Literacy go beyond teaching children how to use technology. They foster digital maturity, equipping students with the judgement, critical thinking and confidence to decide why, when and how technology should be used. The refreshed curricula provide schools with a clear, future-fa
Cubans Protest EU Financing of Havana Regime Amid Rising Tensions24.2.2026 08:05:00 CET | Press release
Cubans from across the United States gathered today in Washington, D.C., outside the Delegation of the European Union, to denounce the EU’s complicity in financing Cuba’s communist state. Protesters held signs reading, “EU, don’t fund the dictatorship,” “Democracies should not fund dictatorships,” and “This march would get me killed in Cuba.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223106922/en/ Cubans from across the United States gathered yesterday in Washington, D.C., outside the Delegation of the European Union, to denounce the EU’s role in financing Cuba’s communist state. The demonstration featured leading Cuban opposition groups including the Assembly of the Cuban Resistance and Cuban Freedom March along with former Cuban political prisoners, Veterans of the Bay of Pigs, Florida State Senator Alexis Calatayud, Miss Universe Cuba 2025 Lina Luaces, and television personality Lili Estefan. Photo: Assembly of th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom